Michael Veeder, MD
Basic profileMichael Veeder is an Oncology physician affiliated with Illinois CancerCare. OpenAlex indexes 38 publications with 4,459 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment$31
- Gilead Sciences, Inc.Program year20211 payment$12
- ADC Therapeutics America, Inc.Program year20211 payment$11
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
52.1%PD-1 inhibitor19.3%Pembrolizumab55%Nivolumab36%Atezolizumab10%Part B, office-administered≥27 patientsCD38-directed Cytolytic Antibody10.3%Daratumumab100%Part B, office-administered≥22 patients+ 17 more classes in this area
Blood & clotting
31.4%Iron, parenteral preparations23.6%Ferric carboxymaltose100%Part B, office-administered≥34 patientsErythropoiesis-stimulating Agent4.1%Darbepoetin alfa100%Part B, office-administered≥14 patients+ 4 more classes in this area
Metabolism & gastrointestinal
9.6%Other antiemetics3.5%Fosaprepitant100%Part B, office-administered≥18 patientsSubstance P/Neurokinin-1 Receptor Antagonist2.6%Aprepitant100%Part B, office-administered≥17 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gary Macvicar, MD
Illinois CancerCare
Nguyet Le-Lindqwister, MD
Illinois CancerCare
Francois Geoffroy, MD
Illinois CancerCare
Paul Fishkin, MD
Illinois CancerCare
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”